8-KItem 2.02 · Results of OperationsItem 8.01 · Other EventsItem 9.01 · Financial Statements
CooperCompanies Retains CooperSurgical and Raises Buyback Authorization to $3 Billion
Filed with the SEC on · Summarized by InvestorsBot
On September 9, 2026, CooperCompanies completed its strategic review and said its board unanimously decided to retain CooperSurgical after determining offers did not adequately reflect shareholder value. The company increased its share repurchase authorization from $2 billion to $3 billion, with approximately $1.5 billion remaining, and reported third-quarter revenue of $1.066 billion, up 1% year over year, while citing planned investments in CooperVision growth and CooperSurgical operations.